What You Should Know:
- 4DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in new institutional placement.
- The investment will primarily be leveraged to accelerate U.S. adoption of its class-leading "CT:VQ™" product and significantly boost research and development—bolstering 4D's technology lead in software-based lung imaging. Backed by new institutional funding, 4DMedical is advancing its respiratory imaging
Read More
AnswersNow Secures $40M to Disrupt Broken Autism Support Systems
What You Should Know:
- AnswersNow, the leader in virtual Applied Behavioral Analysis (ABA) therapy, today announced that it has raised $40 million in Series B funding led by HealthQuest Capital, with participation from existing investors Left Lane Capital, Owl Ventures, and others.
- AnswersNow delivers clinically proven outcomes in one-sixth the hours of traditional therapy, creating substantial cost savings for payors while delivering superior results for families.
AnswersNow Scales
Read More
Zarminali Pediatrics Secures $110M to Solve America’s Child Health Crisis
What You Should Know:
- Zarminali Pediatrics, the first outpatient pediatric destination purpose-built to provide integrated primary and specialty care nationwide, today announced a $110M Series A funding round.
- Healthier Capital led the round, along with participation from existing investor General Catalyst, and new investor K2 HealthVentures.
Zarminali Pediatrics Accelerates Nationwide Expansion to Redefine Family-Centered Pediatric Care
Zarminali Pediatrics is building the
Read More
Arkin Capital Closes $100M Arkin Bio Ventures III to Back Advanced Pre-Clinical to Early Clinical-Stage Biotech Companies
What You Should Know:
- Arkin Capital, a leading multi-asset investment manager, today announced the closing of Arkin Bio Ventures III, a $100 million fund focused on investing in advanced pre-clinical and early clinical-stage biotech companies developing transformative therapies in areas of high unmet medical need.
- The fund is backed by top-tier institutional investors, including Phoenix Insurance, Clal Insurance, and Amitim Pension Funds, alongside a significant investment from Arkin
Read More
RISA Labs Closes $11.1M Series A to Scale AI Operating System for Oncology Nationwide
What You Should Know:
- RISA Labs, a company pioneering AI operating system for oncology, today announced the closing of an $11.1 million Series A funding round.
- The financing was co-led by Cencora Ventures and Optum Ventures, with participation from Oncology Ventures, Z21 Ventures, and John Simon (co-founder of General Catalyst).
RISA Labs Raises the Bar for AI-Driven Oncology Operations
Founded by RISA Labs co-founders Kshitij Jaggi and Kumar Shivang, RISA Labs is building
Read More
EnableComp Acquires H/ROI, Creating the Industry’s Most Comprehensive Complex Revenue Platform
What You Should Know:
- EnableComp®, recognized for resolving the toughest challenges in Complex Revenue Cycle Management, announced its acquisition of Health Resources Optimization, Inc. (H/ROI), a premier clinical denials and revenue recovery firm serving top health systems in the Northeast.
- As hospitals face sustained margin pressure from denials and payer scrutiny, the acquisition expands the revenue EnableComp captures for its clients by resolving and
Read More
Elation Health Cuts Chart Review Time 61% With Anthropic’s Claude AI
What You Should Know:
- Elation Health, the clinical-first technology company powering innovation in primary care, today announced that its Clinical Insights solution has moved to Claude Haiku 4.5 by Anthropic, the leading artificial intelligence research and development company with an emphasis on responsible AI.
- Clinical Insights delivers summaries of a patient's health story to clinicians at the point of care, using Claude’s speed and long-context reasoning for safe, accurate
Read More
Verana Health Acquires COTA to Build Multi-Specialty RWD Powerhouse
What You Should Know:
- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has announced the merger with COTA Healthcare®.
- The merger expands the company’s therapeutic offerings in data and software solutions for real-world insights that accelerate clinical research, expedite treatment options, and improve patient care. Terms of the transaction were not disclosed.
Building a Multi-Specialty Engine for
Read More
Oasys Raises $4.6M to Build the First AI-Native OS for Behavioral Health
What You Should Know:
- Oasys Health ("Oasys"), the first AI-native operating system for behavioral health, today announces $4.6M in funding, including a $4M seed round led by Pathlight Ventures, with participation from Twine Ventures and Better Ventures, and $600K in pre-seed funding from 1984 Ventures.
- As demand for mental health support surges, Oasys will use new capital to enhance its AI-powered platform, deepen integrations with leading wearables and health apps, grow its
Read More
Teal Health Expands Nationwide – Bringing FDA Authorized At-Home Cervical Cancer Screening to All 50 States
What You Should Know:
- Teal Health, a virtual women’s health company on a mission to eliminate cervical cancer in the U.S., today announced the national availability of its comprehensive telehealth platform and its FDA-authorized self-collection device for at-home cervical cancer screening, the Teal Wand™. Cervical cancer screening, often referred to as the pap smear, is a recommended screening for all women ages 25-65.
- In May 2025, Teal received FDA-authorization, and now just seven
Read More
